CSF3 and hepatocellular carcinoma: Similar results were reported by Miyahara et al., who found that high baseline levels of serum cytokines, including Ang-2, granulocyte colony-stimulating factor (G-CSF), hepatocyte growth factor (HGF), and leptin were correlated with poor treatment effects of sorafenib in HCC patients (45).